Skip to content

Does losartan help migraines? Unpacking the evidence

4 min read

According to a meta-analysis, the class of drugs that includes losartan—angiotensin II receptor blockers (ARBs)—shows a moderate to large effect on reducing migraine frequency, with some individual ARBs showing fair to good evidence of efficacy. This suggests losartan could potentially help migraines, although its use for this condition is considered off-label and warrants careful medical consideration.

Quick Summary

Investigate the evidence behind using losartan for migraine prevention. This article discusses its mechanism, compares it to other ARB medications, and outlines potential benefits and side effects.

Key Points

  • Losartan is not FDA-approved for migraines: Its use for this purpose is considered off-label, and other medications may have stronger evidence.

  • Angiotensin II Receptor Blockers (ARBs) show promise: Losartan is in the ARB drug class, which has demonstrated a moderate to large effect on reducing migraine frequency in general studies.

  • Stronger evidence exists for other ARBs: For example, candesartan has more established clinical trial data supporting its use for migraine prophylaxis.

  • Modulates the renin-angiotensin system: Losartan's mechanism involves blocking the effects of angiotensin II, which is thought to play a role in migraine development.

  • Potential for dual benefit: Patients with comorbid hypertension might find losartan beneficial for both blood pressure management and migraine prevention.

  • Headaches can be a side effect: Some patients experience headaches or even migrainous headaches when taking losartan, complicating its use for migraine prevention.

  • Requires medical supervision: Due to the off-label use and potential side effects, losartan should only be taken for migraine under the guidance of a healthcare professional.

In This Article

What is Losartan and How Does it Work?

Losartan, also known by the brand name Cozaar, is a prescription medication belonging to a class of drugs called angiotensin II receptor blockers, or ARBs. It is primarily FDA-approved to treat high blood pressure, lower the risk of stroke in certain patients with high blood pressure and an enlarged heart, and manage kidney problems in patients with type 2 diabetes and hypertension.

The mechanism behind its primary use involves blocking the action of angiotensin II, a powerful chemical in the body that causes blood vessels to constrict. By blocking the receptors for angiotensin II, losartan helps blood vessels relax and widen, which lowers blood pressure. This same mechanism is thought to be relevant to migraine prevention.

The Renin-Angiotensin System and Migraine Prophylaxis

Research suggests that the renin-angiotensin system (RAS), which losartan influences, may play a role in migraine pathophysiology. By modulating the activity of the RAS, ARBs may help prevent migraine attacks. Several studies have investigated the use of ARBs for migraine prophylaxis, with varying results across different drugs in the class.

Evidence for Other ARBs in Migraine Prevention While losartan is sometimes considered for this purpose, evidence for other ARBs is more robust. Candesartan (Atacand) is one of the more studied ARBs for migraine prevention. A clinical trial involving 60 patients demonstrated that candesartan significantly reduced monthly headache days, migraine days, and migraine hours compared to a placebo. Telmisartan has also shown promise in reducing migraine days.

Limited Direct Evidence for Losartan Direct clinical evidence specifically for losartan's efficacy in migraine prevention is less established than for candesartan. Some user reports and older studies show mixed results, with some individuals finding relief and others reporting headaches as a side effect. A meta-analysis concluded that ARBs overall have a positive effect, but providers should consider options like candesartan or lisinopril (an ACE inhibitor) where stronger evidence of efficacy exists. This highlights that while the drug class is promising, individual drugs within the class may have different effects for migraine prophylaxis.

Potential Benefits and Considerations

For some patients, particularly those who have comorbid hypertension, using losartan to manage blood pressure could offer the dual benefit of potentially reducing migraine frequency. The potential advantages of using losartan or other ARBs for migraine prophylaxis include:

  • Good tolerability: Losartan is generally well-tolerated by many patients.
  • Alternative for ACE inhibitor intolerance: Unlike ACE inhibitors, ARBs like losartan do not typically cause a persistent cough, making them a suitable alternative for those who cannot tolerate ACE inhibitors.
  • Dual-purpose treatment: It can be a convenient option for patients with both hypertension and migraines.

Losartan Compared to Other Migraine Prophylactics

Below is a comparison of losartan with other common types of medications used for migraine prevention:

Feature Losartan (ARB) Beta-Blockers (e.g., Propranolol) Antidepressants (e.g., Amitriptyline) CGRP Monoclonal Antibodies
Primary Indication Hypertension Hypertension, Angina Depression, Neuropathic Pain Migraine Prevention
Primary FDA Status for Migraine Off-label Approved Off-label Approved
Mechanism for Migraine Modulates renin-angiotensin system Affects central nervous system and vascular tone Neuromodulatory effect on pain pathways Targets calcitonin gene-related peptide
Effectiveness Some evidence, but less robust than other ARBs like candesartan Well-established for migraine prevention Fairly effective for chronic migraine High efficacy specifically for migraine prevention
Common Side Effects Dizziness, headache, nasal congestion Fatigue, dizziness, low blood pressure Sedation, dry mouth, weight gain Injection site reactions, constipation
Patient Profile Patients with comorbid hypertension Patients with comorbid anxiety, hypertension Patients with comorbid anxiety, depression Patients with frequent, severe migraines

Risks and Side Effects of Losartan

While often well-tolerated, losartan can cause side effects that may impact migraine sufferers. It's crucial to consult a healthcare provider before starting or stopping any medication. Common side effects can include:

  • Dizziness or lightheadedness
  • Upper respiratory infection symptoms, such as stuffy nose
  • Back pain
  • Fatigue
  • Insomnia

More serious side effects are less common but may include low blood pressure, kidney problems, high potassium levels, and allergic reactions. Headaches, and in rare cases, severe migrainous headaches, have also been reported with losartan use. This conflicting report of headaches as both a potential symptom and a potential side effect highlights the importance of individualized treatment under medical supervision.

The Importance of Medical Supervision

Because using losartan for migraine is an off-label use, it is critical that patients do so only under the direct supervision of a healthcare provider. A doctor can evaluate your medical history, current medications, and other conditions (such as hypertension or kidney issues) to determine if losartan is an appropriate option for you. They can also monitor your progress and manage potential side effects, adjusting the dosage as necessary.

Conclusion

While losartan is not an FDA-approved treatment specifically for migraine, its class of drugs, the ARBs, has shown promise in migraine prophylaxis by modulating the renin-angiotensin system. Evidence for other ARBs like candesartan is more compelling, and direct data for losartan's effectiveness specifically for migraine prevention is limited. For individuals with both hypertension and migraines, it may be a viable option, but it is not a first-line treatment. Because headaches can also be a side effect, close monitoring by a healthcare provider is essential to determine if losartan helps migraines in your specific case, weighing the potential benefits against the risks. Ultimately, patients should discuss all medication options with their doctor to find the most suitable prophylactic treatment for their needs. For further clinical information on the effectiveness of ARBs for migraine, you can consult research indexed on the National Institutes of Health website.

Frequently Asked Questions

No, losartan is not FDA-approved for the treatment or prevention of migraines. It is approved for managing high blood pressure, reducing stroke risk in certain patients, and treating diabetic nephropathy.

ARBs are believed to help prevent migraines by modulating the renin-angiotensin system (RAS), which is involved in blood pressure regulation. This modulation may counteract mechanisms thought to trigger migraine attacks.

Not necessarily. Evidence for the effectiveness of losartan specifically for migraine prevention is limited compared to other ARBs, such as candesartan, which has been more extensively studied and shown to be effective in clinical trials.

Common side effects include dizziness, nasal congestion, upper respiratory infections, and back pain. In some cases, headaches can also occur.

Yes, headaches can be a side effect of losartan, especially when treatment is first initiated. In rare cases, severe migrainous headaches have also been reported.

Losartan may be considered for patients who have both high blood pressure and migraines, as it could potentially offer a dual benefit. However, this should always be discussed with and monitored by a doctor.

Medical supervision is crucial because its use for migraines is off-label, efficacy varies, and there's a risk of side effects like headaches or low blood pressure. A doctor can determine if it's safe and effective for your specific condition.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.